Richards, Merrill & Peterson, Inc. Lantern Pharma Inc. Put Options Transaction History
Richards, Merrill & Peterson, Inc.
- $191 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LTRN
# of Institutions
35Shares Held
2.48MCall Options Held
4.6KPut Options Held
600-
Bios Capital Management, LP Fort Worth, TX1.21MShares$5.91 Million4.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$1.78 Million0.0% of portfolio
-
Cm Management, LLC200KShares$977,9990.6% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny87.3KShares$426,8970.0% of portfolio
-
Geode Capital Management, LLC Boston, MA87KShares$425,2970.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $53M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...